A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value-Reference-Cited by-同舟云学术

A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value

Published:2013-08-26 Issue:19 Volume:119 Page:3454-3461
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Lu Karen H.¹,Skates Steven²,Hernandez Mary A.³,Bedi Deepak⁴,Bevers Therese⁵,Leeds Leroy⁶,Moore Richard⁷,Granai Cornelius⁷,Harris Steven⁸,Newland William⁹,Adeyinka Olasunkanmi¹⁰,Geffen Jeremy¹¹,Deavers Michael T.¹²,Sun Charlotte C.¹,Horick Nora²,Fritsche Herbert³,Bast Robert C.³

Affiliation:

1. Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Biostatistics Center (Harvard Medical School); Massachusetts General Hospital; Boston Massachusetts

3. Office of Translational Research; The University of Texas MD Anderson Cancer Center; Houston Texas

4. Department of Diagnostic Radiology; The University of Texas MD Anderson Cancer Center; Houston Texas

5. Department of Clinical Cancer Prevention; The University of Texas MD Anderson Cancer Center; Houston Texas

6. OGA Medical Center; Houston Texas

7. Women & Infants Hospital; Brown University; Providence Rhode Island

8. OB/GYN Associates of Dallas; Dallas Texas

9. Women's Clinic; The Iowa Clinic; West Des Moines Iowa

10. The University of Texas Family Physicians; Houston Texas

11. Geffen Cancer Center and Research Institute; Vero Beach Florida

12. Department of Pathology and Clinical Pathology; The University of Texas MD Anderson Cancer Center; Houston Texas

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28183/fullpdf

Reference7 articles.

1. Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers;Skates;Cancer.,1995

2. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial;Buys;Am J Obstet Gynecol.,2005

3. Risk of diagnosis of ovarian cancer after raised serum CA125 concentration: a prospective cohort study;Jacobs;BMJ.,1996

4. Screening based on the risk of cancer calculation from Bayesian hierarchical changepoint and mixture models of longitudinal markers;Skates;J Am Stat Assoc.,2001

5. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women;Skates;J Clin Oncol.,2003

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Grade Serous Ovarian Cancer—A Risk Factor Puzzle and Screening Fugitive;Biomedicines;2024-01-19

2. Normal Risk Ovarian Screening Study: 21-Year Update;Journal of Clinical Oncology;2024-01-09

3. Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer;British Journal of Cancer;2024-01-09

4. Lineage specific extracellular vesicle-associated protein biomarkers for the early detection of high grade serous ovarian cancer;Scientific Reports;2023-10-26

5. Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies;Cancers;2023-10-20